Showing the single result
Favipiravir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pyrazinecarboxamide derivative.
Active Ingredient Strength Primary Clinical Function Favipiravir USP/Ph.Eur. 200 mg The Global Outbreak Standard: Base therapeutic unit utilized for standard, highly flexible titration during acute viral hemorrhagic fevers or novel influenza outbreaks. Favipiravir USP/Ph.Eur. 400 mg / 800 mg The Pill-Burden Reduction Macrodose: Massive therapeutic payload engineered specifically to solve the severe “Day 1 Loading Dose” compliance nightmare (allowing a patient to take two 800mg pills instead of eight 200mg pills). Excipients Microcrystalline Cellulose / Crospovidone / Povidone K-30 / Colloidal Silicon Dioxide / Sodium Stearyl Fumarate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Lubricant (Engineered specifically utilizing advanced high-shear wet granulation to compress massive, bulky API doses into smooth, easily swallowable tablets, finished with a heavy film-coat to lock out tropical humidity) *Pack Sizes: 10×10 Alu-Alu Blisters or Complete Therapy “Outbreak Kits” (e.g., 34-tablet or 40-tablet regimen boxes).
